| For: | Ignatowski TA, Spengler RN. Targeting tumor necrosis factor in the brain relieves neuropathic pain. World J Anesthesiol 2018; 7(2): 10-19 [DOI: 10.5313/wja.v7.i2.10] | 
|---|---|
| URL: | https://www.wjgnet.com/2218-6182/full/v7/i2/10.htm | 
| Number | Citing Articles | 
| 1 | 
                             
                                            Stephen J. Ralph, Andrew Weissenberger, Ventzislav Bonev, Liam D. King, Mikaela D. Bonham, Samantha Ferguson, Ashley D. Smith, Adrienne A. Goodman-Jones, Anthony J. Espinet. Phase I/II parallel double-blind randomized controlled clinical trial of perispinal etanercept for chronic stroke: improved mobility and pain alleviation. Expert Opinion on Investigational Drugs 2020; 29(3): 311 doi: 10.1080/13543784.2020.1709822
                                         
                                     | 
                    
| 2 | 
                             
                                            Fariba Namdar, Farideh Bahrami, Zahra Bahari, Bahram Ghanbari, Shima Shahyad, Mohammad Taghi Mohammadi. Fullerene C60 nanoparticle attenuates pain and tumor necrosis factor-α protein expression in hippocampus following diabetic neuropathy in rats. Physiology and Pharmacology 2021; 0(Accepted Manuscripts): 0 doi: 10.52547/phypha.26.4.5
                                         
                                     | 
                    
| 3 | 
                             
                                            Konrad Rejdak, Halina Sienkiewicz‐Jarosz, Przemyslaw Bienkowski, Anton Alvarez. Modulation of neurotrophic factors in the treatment of dementia, stroke and TBI: Effects of Cerebrolysin. Medicinal Research Reviews 2023; 43(5): 1668 doi: 10.1002/med.21960
                                         
                                     | 
                    
